Form D · Other Health Care

Restor Metabolix Inc

Carrollton, GA · CIK 0001901338

Offering snapshot reported Oct 27, 2022 · SEC filing

Reported sold
$1M
Offering amount: $3M
Investors reported
0
Form D · investor count
Minimum accepted
$30K
Reported outside-investor minimum
First sale
Oct 15, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 27, 2022Initial$1,000,000No comparison0SEC filing
Jan 3, 2022Initial$0No comparison0SEC filing

Offering details

Securities
Debt
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-462953

Source: Form D, filed Oct 27, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Demarco Bell Director
Randy Crawford Director
Dan Dunn Executive
Charles K Edwards Director
William H Gafford Director
Christopher Gaunder Director
Tom Greene Director
Nicholas Reiter Director
Jouko J Rissanen Executive
Michael Rozmajzl Director
Jeff Smith Director
Jeffrey A Smith Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
108 Turnberry Circle
Carrollton, GA, 30116